Skip to content
Open access

Population-Based Cohort Study: Colorectal Cancer Risk Stratification in Symptomatic Patients Using the Faecal Immunochemical Test, Blood Results and Patient Characteristics in Wales.

Oct 2026 · Alimentary Pharmacology and Therapeutics · 1 citation · 24 references
Medicine

TL;DR

In Wales, the risk of CRC following FIT ≥ 10 μgHb/g is higher than observed in English and Scottish cohorts, but this did not fully explain the higher baseline risk observed in comparison to other UK nations.

Abstract

Background

Wales has the highest rate of colorectal cancer (CRC) in the UK. National guidelines recommend using the faecal immunochemical test (FIT) in patients presenting with symptoms of bowel cancer. FIT ≥ 10 μgHb/g in symptomatic patients is presumed to indicate a > 3% risk of CRC. However, evidence from England and Scotland has found that the risk is lower in certain demographic groups.

Aims

To examine 1-year risk of CRC in Welsh patients with symptoms of suspected bowel cancer by demographics, iron deficiency anaemia (IDA), and FIT.

Methods

Cohort study of adults registered in the Welsh Longitudinal General Practice dataset with a FIT recorded from 01/01/2020-31/03/2024. Kaplan-Meier estimates were used to calculate 1-year cumulative risks of CRC.

Results

We included 166,863 patients with a FIT; 19.2% had a FIT ≥ 10 μgHb/g. Within 1 year, 2864 (1.72%) were diagnosed with CRC; 90.2% of which were following FIT ≥ 10μgHb/g. A FIT cut-off of ≥ 10 μgHb/g in isolation identified a > 3% risk of CRC across all age groups. In those with FIT ≥ 10μgHb/g, IDA resulted in an increase in predicted risk across all age groups. IDA aided stratification further in women < 50 years; risk of CRC was 6.45% (95% CI: 3.52-9.29) with a FIT ≥ 10 μgHb/g and IDA compared to 2.20% (95% CI: 1.57-2.83) without IDA.

Conclusions

In Wales, the risk of CRC following FIT ≥ 10 μgHb/g is higher than observed in English and Scottish cohorts. Stratification by demographics and blood results identified those at highest risk, but this did not fully explain the higher baseline risk observed in comparison to other UK nations.

Read PDF

Similar papers

Sep 2026

Three-year outcomes and alternative diagnoses in FIT-positive symptomatic patients without colorectal cancer: a real-world cohort study

Faecal immunochemical testing (FIT) is widely used to triage symptomatic patients for colorectal cancer (CRC), but it is not disease-specific and may reflect a range of alternative bleeding-related pathologies. We aimed to characterise alternative diagnoses and their association with FIT levels in FIT-positive symp...

Z. Tee, Ellen L. Rumsby, Arash Assadsangabi · 0 citations
Open access Oct 2026

Routes to Diagnosis and Stage at Diagnosis of Colorectal Cancer in Patients Aged ≥ 50 Years: A Multicentre Retrospective Cohort Study From North Wales, UK

‘Route to diagnosis’, the clinical pathway through which a cancer is first identified, is associated with stage at presentation in colorectal cancer (CRC), but recent regional data in the UK describing this relationship following the wider adoption of symptomatic faecal immunochemical testing (FIT) is limited. This stu...

Mikaella Toquero, Sushmitha Thiagarajah Naidu, Anna Williams et al. · 0 citations
Open access Sep 2026

Impact of the Australian National Bowel Cancer Screening Program on Stage at Diagnosis and Stage-Specific Survival in Colorectal Cancer.

Screen-detected colorectal cancer is associated with earlier stage at diagnosis and improved survival in stage III disease, and these findings support the role of screening in earlier diagnosis and improved oncological outcomes.

Michael Rouse, M. Harold, V. Wong et al. · 0 citations
Sep 2026

Assessment of Risk Factors Associated with Colorectal Cancer among Patients in a Tertiary Care Cancer Centre: A Hospital-based Observational Study

Background: Colorectal cancer (CRC) is a leading cause of morbidity and mortality related to cancer globally, with a rapidly increasing incidence in Asia due to urbanization and lifestyle changes. A hospital-based case-control A study was performed at the Erode Cancer Centre, Erode, Tamil Nadu, India to evaluate the so...

Dhivyaprasath Palaniappan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.